SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-19-005782
Filing Date
2019-12-02
Accepted
2019-12-02 20:29:40
Documents
1
Period of Report
2019-12-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 7753
  Complete submission text file 0001562180-19-005782.txt   9159
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Issuer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O MAGENTA THERAPEUTICS 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
COOKE MICHAEL P. (Reporting) CIK: 0001741288 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38541 | Film No.: 191264382